![]() Weakness in UnitedHealth's Medicaid program weighed on the segment, and some seasonal factors also were at play in holding the company back. Revenue climbed 11% in the fourth quarter compared to the year-earlier period, although operating earnings were higher by only 2% over the same time frame. ![]() The UnitedHealthcare division was only slightly behind. OptumRx brought up the rear with 9% growth in sales, with 1.34 billion prescriptions filled during the year. OptumInsight also posted double-digit-percentage growth for 2018 on strength in its data analytics services. ![]() OptumHealth saw the biggest sales gains during the year, with the health management business serving 93 million members at year-end. Quarterly sales growth of 13% resulted in a 22% jump in the segment's operating profit, and UnitedHealth pointed to efforts to boost margin as particularly important in Optum's overall improvement. One of the highlights that UnitedHealth emphasized was its Optum unit's surpassing the $100 billion mark in annual revenue. Net income came in at $3.04 billion, and after accounting for some one-time items, adjusted earnings of $3.28 per share were up 27% from year-ago levels and topped the consensus forecast for $3.21 per share. Sales came in at $58.4 billion, topping the $58 billion forecast among those following the stock and rising by about 12% from the fourth quarter of 2017. UnitedHealth's fourth-quarter results continued a long string of good results for the company.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |